What fluid‑resuscitation regimen was shown to be optimal in the Waterfall trial for adults with acute pancreatitis presenting within the first 24 hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

WATERFALL Trial Fluid Resuscitation Protocol for Acute Pancreatitis

The WATERFALL trial demonstrated that moderate fluid resuscitation (10 ml/kg bolus in hypovolemic patients or no bolus in normovolemic patients, followed by 1.5 ml/kg/hr) is superior to aggressive fluid resuscitation for adults with acute pancreatitis, as aggressive resuscitation resulted in nearly 3-fold increased risk of fluid overload without improving clinical outcomes. 1

Optimal Fluid Resuscitation Regimen from WATERFALL Trial

Moderate Resuscitation Protocol (Recommended)

  • Initial bolus: 10 ml/kg in patients with hypovolemia OR no bolus in patients with normovolemia 1
  • Maintenance rate: 1.5 ml/kg/hr for all patients 1
  • Reassessment: At 12,24,48, and 72 hours with adjustments based on clinical status 1

Aggressive Resuscitation Protocol (NOT Recommended)

  • Initial bolus: 20 ml/kg 1
  • Maintenance rate: 3 ml/kg/hr 1
  • This protocol resulted in 20.5% fluid overload rate vs. 6.3% with moderate resuscitation (adjusted RR 2.85,95% CI 1.36-5.94) 1

Key Clinical Outcomes from WATERFALL Trial

Primary Outcome

  • No difference in development of moderately severe or severe pancreatitis: 22.1% (aggressive) vs. 17.3% (moderate); adjusted RR 1.30,95% CI 0.78-2.18 1

Safety Outcomes Favoring Moderate Resuscitation

  • Fluid overload: 20.5% (aggressive) vs. 6.3% (moderate); adjusted RR 2.85,95% CI 1.36-5.94 1
  • Hospital length of stay: 6 days (aggressive) vs. 5 days (moderate) 1
  • Trial was halted early at interim analysis due to safety concerns without efficacy benefit 1

Supporting Evidence from Meta-Analysis

Mortality Risk with Aggressive Hydration

  • In severe AP: Aggressive hydration increased mortality risk (pooled RR 2.45,95% CI 1.37-4.40 in Asian populations) 2
  • Meta-analysis of 3 RCTs showed increased sepsis risk with aggressive hydration (pooled RR 1.44,95% CI 1.15-1.80) 2

Fluid-Related Complications

  • Severe AP: Aggressive hydration increased fluid-related complications (pooled RR 2.22,95% CI 1.36-3.63) 2
  • Non-severe AP: Aggressive hydration increased fluid-related complications (pooled RR 3.25,95% CI 1.53-6.93) 2

Clinical Deterioration Markers

  • In severe AP, aggressive hydration worsened APACHE II scores (pooled MD 3.31,95% CI 1.79-4.84) 2
  • No improvement in clinical outcomes for non-severe AP with aggressive protocols 2

Current Guideline Context

American Gastroenterological Association (2018)

  • Recommends goal-directed therapy for fluid management (conditional recommendation, very low quality evidence) 2
  • Makes no specific recommendation on optimal initial rate of fluid resuscitation due to paucity of evidence at that time 2
  • This guideline predates the WATERFALL trial findings 2

Fluid Type Recommendation

  • Ringer's lactate preferred over normal saline for reducing SIRS, organ failure, and ICU stays 3
  • Colloids associated with adverse events including renal impairment and coagulopathy 3

Critical Clinical Pitfalls to Avoid

Avoid Aggressive Resuscitation in These Scenarios

  • Cardiovascular comorbidities: Risk of fluid overload substantially increased 2
  • Renal comorbidities: Increased risk of acute kidney injury 2
  • Severe AP: Highest risk of mortality with aggressive protocols 2
  • Non-severe AP: No benefit with increased complication risk 2

Assessment Points for Fluid Adjustment

  • 12-hour mark: First reassessment of volume status and clinical response 1
  • 24-hour mark: Critical timepoint for detecting fluid overload (rapid weight gain, ascites, jugular vein engorgement) 2
  • 48-hour mark: Evaluate for persistent SIRS, organ failure development 2
  • 72-hour mark: Final protocol-specified reassessment 1

Monitoring Parameters

  • Volume status indicators: Weight changes, presence of ascites, jugular venous distension 2
  • Organ function: Hematocrit, BUN, creatinine changes within 48 hours 2
  • SIRS criteria: Temperature, heart rate, respiratory rate, white blood cell count 2
  • Respiratory status: Oxygen requirements, signs of pulmonary edema 2

Algorithm for Implementation

Step 1: Assess volume status on presentation 1

  • Hypovolemic: Give 10 ml/kg bolus
  • Normovolemic: No bolus

Step 2: Initiate maintenance at 1.5 ml/kg/hr with lactated Ringer's solution 1, 3

Step 3: Reassess at 12,24,48, and 72 hours 1

  • Monitor for fluid overload signs
  • Adjust rate based on clinical response
  • Reduce or stop if overload develops

Step 4: Continue goal-directed adjustments beyond 72 hours as clinically indicated 2

References

Research

Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis.

The New England journal of medicine, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.